Success Story: NIW Approved Without an RFE! We Helped a Cancer Biology Expert Secure Success
Client’s Testimonial:
"I deeply appreciate all your patience, guidance, and professional support throughout my case.”
On August 21st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Staff Scientist
Country of Origin: China
State of Residence at the Time of Filing: Texas
Approval Notice Date: August 21st, 2026
Processing Time: 2 months, 17 days (Premium Processing Upgrade Requested)
Case Summary:
The client, a Ph.D. in microbial and biochemical pharmacy, was approved under the EB-2 National Interest Waiver (NIW) category for her research in cancer biology and related biomedical sciences. Her proposed endeavor focuses on advancing the understanding of disease mechanisms, developing innovative research models and methodologies, and generating findings that may support improved diagnosis, prevention, and treatment strategies.
She is currently employed as a staff scientist at a U.S.-based medical research institution and has secured a future research role at another U.S. medical center. Her work supports translational cancer biology research, including studies of thoracic malignancies, treatment resistance, molecular signaling pathways, and therapeutic strategies that may help improve disease control and patient survival.
The petition demonstrated that the client has developed a focused and steadily advancing research portfolio in the broader field of cancer biology and biomedical research. Her work addresses important questions concerning how diseases develop, progress, and respond to treatment, with particular attention to the biological processes that influence cellular behavior and therapeutic outcomes. Through her research, she has contributed to the study of cancer progression, cellular stress responses, molecular and mitochondrial regulation, treatment resistance, and the development of experimental models used to better understand disease mechanisms.
Her work also involves applying modern laboratory and analytical approaches to investigate complex biological systems and identify factors that may affect the effectiveness of existing and emerging therapies. These efforts have helped generate knowledge that may support future research in disease prevention, diagnosis, treatment development, and precision medicine. More broadly, the client’s research contributes to the advancement of biomedical science by improving the understanding of cancer-related mechanisms and providing a foundation for continued investigation into more effective and individualized treatment strategies.
Strong Academic and Research Record
The client has established a solid scholarly profile, including:
- 11 peer-reviewed journal articles, including 1 first-authored and 2 co-first-authored articles
- 5 conference abstracts, including 2 first-authored abstracts
- 5 granted patents
- 327 citations to her published work
At least 60 peer reviews for journals in cancer biology, oncology, immunology, and related fields
These outputs were presented as concentrated contributions in a specialized area of cancer biology. The citation record was analyzed as evidence of meaningful independent reliance, showing that other researchers had used the client’s findings in studies involving cancer biology, disease mechanisms, cellular signaling, molecular regulation, and related areas of biomedical research.
The petition also explained the citation record in context. The client authored 1 paper ranked among the top 10% and 2 papers ranked among the top 20% most-cited articles for their respective publication years, helping demonstrate that her research had gained attention beyond ordinary publication.
Funding and National Importance
The client’s work has been supported by major U.S. research funding sources, including the National Cancer Institute (NCI), the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging (NIA), the National Institute of General Medical Sciences (NIGMS), and the National Science Foundation (NSF). This funding underscored the national relevance of her research in advancing cancer biology, biotechnology, disease mechanisms, and public health.
North America Immigration Law Group (NAILG) demonstrated the national importance of the proposed endeavor by connecting the client’s research to broader healthcare and public health priorities in the United States. The petition emphasized that her work may contribute to a better understanding of disease mechanisms, support the development of improved treatment strategies, advance precision medicine, improve patient outcomes, and help reduce the overall burden of serious diseases on the healthcare system.
Testimonial Support and Approval
The petition included testimonial letters confirming the client’s planned research projects, collaborations, and the broader significance of her work to the United States. These letters helped establish that her research on therapy resistance, thoracic cancers, and precision oncology is relevant to ongoing national efforts to improve cancer treatment and patient outcomes.
Overall, USCIS approved the NIW petition without issuing a Request for Evidence. The approval recognized the national importance of the client’s cancer biology research and her demonstrated ability to advance studies of therapy resistance, precision oncology, and translational cancer research in the United States.